Product Code: RP-ID-10013013 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10013013
Market Overview:
Global Insulin Delivery Devices Market Size Study, By Type (Insulin Pens, Insulin Pumps, Insulin Injectors, Insulin Syringes), By End User (Homecare, Hospitals and others ) and Regional (North America, Europe, Asia Pacific, Latin America, and Rest of the World) Forecasts, 2017-2025 (USD Billion/Million)
Global Insulin Delivery Devices valued approximately USD 11.54 Billion in 2016 is anticipated to grow with healthy growth rate of more than 9.10% over the forecast period 2017-2025. The Key drivers in the market include Government support in specific countries, favorable reimbursement technological advancements in insulin delivery devices, and rising diabetic population.
The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Product Type:
 Insulin syringes
 Insulin pens
 Insulin pumps
 Insulin injectors
End-Use:
 Hospital
 Homecare
 Others
Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, the years considered for the study are as follows:
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market are Novo Nordisk A/S, Sanofi, Eli Lilly and Company Biocon Ltd. Wockhardt Ltd and Medtronic. The companies are spending a lot on their research and development programs to keep up with the dynamically changing technologies in the market. Acquisitions and effective mergers are one of the expansion strategies taken by the key manufacturers.
Target Audience of the Insulin Delivery Devices Market Study
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Please note that owing to the criticality of the Insulin Delivery Devices market and rapidly changing market attributes, we are in the middle of updating the report. The final report may require 2 to 3 working days post-confirmation in order to cater to the most recent updates.
Eli Lilly and Company
Biocon Ltd.
Abbott Laboratories .
Wockhardt Ltd.
Becton, Dickinson and Company.
F. Hoffmann-La Roche, Ltd.
Tandem Diabetes Care, Inc.
Insulet Corporation
Related Reports
Proof of Quality & Reliability
